Total Payments
$511.01
2024 Payments
$5.46
Companies
13
Transactions
20
Medicare Patients
2,950
Medicare Billing
$460,157
Payment Breakdown by Category
Food & Beverage$436.93 (85.5%)
Education$74.08 (14.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $436.93 | 15 | 85.5% |
| Education | $74.08 | 5 | 14.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $149.75 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $65.54 | 2 | $0 (2023) |
| Novo Nordisk Inc | $58.17 | 3 | $0 (2022) |
| Zealand Pharma US, Inc. | $48.23 | 1 | $0 (2021) |
| Amgen Inc. | $44.73 | 2 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $39.83 | 1 | $0 (2017) |
| Abbott Laboratories | $22.49 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $16.70 | 1 | $0 (2018) |
| Sandoz Inc. | $15.34 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $14.25 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5.46 | 2 | Travere Therapeutics, Inc. ($5.46) |
| 2023 | $74.30 | 3 | GlaxoSmithKline, LLC. ($39.14) |
| 2022 | $103.94 | 5 | Novo Nordisk Inc ($36.70) |
| 2021 | $227.54 | 5 | AstraZeneca Pharmaceuticals LP ($117.67) |
| 2020 | $14.25 | 1 | Janssen Pharmaceuticals, Inc ($14.25) |
| 2018 | $16.70 | 1 | Merck Sharp & Dohme Corporation ($16.70) |
| 2017 | $68.82 | 3 | Bard Peripheral Vascular, Inc. ($39.83) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 04/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 12/12/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/28/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Education | In-kind items and services | $39.14 | General |
| Category: NEPHROLOGY | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Education | In-kind items and services | $26.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Nephrology | ||||||
| 04/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardio-renal | ||||||
| 11/01/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Nephrology | ||||||
| 10/01/2021 | Zealand Pharma US, Inc. | ZEGALOGUE (Drug) | Food and Beverage | In-kind items and services | $48.23 | General |
| Category: 1 | ||||||
| 09/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $117.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 03/15/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Diabetes Care | ||||||
| 12/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/13/2017 | Bard Peripheral Vascular, Inc. | BPV-Fluency (Device) | Food and Beverage | Cash or cash equivalent | $39.83 | General |
| Category: Vascular | ||||||
| 02/01/2017 | Sandoz Inc. | ZARXIO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2017 | Midatech Pharma US Inc | Zuplenz (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 697 | 1,030 | $208,762 | $87,924 |
| 2022 | 20 | 744 | 1,079 | $227,313 | $98,100 |
| 2021 | 23 | 804 | 1,275 | $305,043 | $142,640 |
| 2020 | 17 | 705 | 1,253 | $324,929 | $131,492 |
Total Patients
2,950
Total Services
4,637
Medicare Billing
$460,157
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 118 | $22,650 | $11,753 | 51.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 167 | $22,545 | $11,154 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 171 | $23,256 | $9,897 | 42.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 38 | $23,980 | $9,241 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 124 | $25,012 | $8,818 | 35.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 75 | 143 | $25,454 | $8,599 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $14,430 | $6,494 | 45.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 44 | $15,620 | $6,417 | 41.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 37 | $9,102 | $4,066 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 22 | $5,984 | $2,839 | 47.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 15 | $7,560 | $2,694 | 35.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 44 | 52 | $4,420 | $2,180 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,795 | $1,665 | 59.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 21 | $3,502 | $1,163 | 33.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 13 | $2,340 | $913.12 | 39.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $112.00 | $30.80 | 27.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 24 | 57 | $39,900 | $17,166 | 43.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 41 | $24,190 | $10,377 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 120 | $22,800 | $9,672 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 133 | $17,968 | $8,909 | 49.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 50 | $17,750 | $8,401 | 47.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 63 | 132 | $23,496 | $8,164 | 34.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 63 | 132 | $17,820 | $7,976 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $13,320 | $6,541 | 49.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 58 | $11,020 | $5,037 | 45.7% |
About Dr. Jarrod Post, MD
Dr. Jarrod Post, MD is a Nephrology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811096845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jarrod Post, MD has received a total of $511.01 in payments from pharmaceutical and medical device companies, with $5.46 received in 2024. These payments were reported across 20 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($436.93).
As a Medicare-enrolled provider, Post has provided services to 2,950 Medicare beneficiaries, totaling 4,637 services with total Medicare billing of $460,157. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Hartford, CT
- Active Since 09/22/2006
- Last Updated 02/21/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1811096845
Products in Payments
- FARXIGA (Drug) $149.75
- ZEGALOGUE (Drug) $48.23
- Parsabiv (Drug) $44.73
- BPV-Fluency (Device) $39.83
- JESDUVROQ (Drug) $39.14
- Ozempic (Drug) $34.29
- BENLYSTA (Biological) $26.40
- Rybelsus (Drug) $23.88
- FreeStyle Libre (Device) $22.49
- JANUVIA (Drug) $16.70
- ZARXIO (Drug) $15.34
- XARELTO (Drug) $14.25
- Kerendia (Drug) $13.79
- Zuplenz (Drug) $13.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Hartford
Xiaoyi Ye, M.d, M.D
Nephrology — Payments: $25,451
Nephrology $25,451
Dr. Terrence Oder, M.d, M.D
Nephrology — Payments: $2,215
Nephrology $2,215
Dr. Scott Benson, Do, DO
Nephrology — Payments: $1,598
Nephrology $1,598
Diana Moise, Md, MD
Nephrology — Payments: $1,257
Nephrology $1,257
Dr. Joseph Singh, M.d, M.D
Nephrology — Payments: $1,122
Nephrology $1,122
Timothy Curley, Md, MD
Nephrology — Payments: $756.36
Nephrology $756.36